Indian sickle cell disease registry for surveillance and patient management: Development and implementation

被引:3
|
作者
Babu, Bontha V. V. [1 ,2 ]
Sharma, Yogita [2 ]
Surti, Shaily B. B. [3 ]
Bhat, Deepa [4 ]
Sridevi, Parikipandla [5 ]
Ranjit, Manoranjan [6 ]
Sudhakar, Godi [7 ]
Sarmah, Jatin [8 ]
机构
[1] Indian Council Med Res, Div Sociobehav & Hlth Syst Res, New Delhi, India
[2] Indian Council Med Res, Div Sociobehav Hlth Syst & Implementat Res, New Delhi 110029, India
[3] Parul Univ, Parul Inst Med Sci & Res, Dept Community Med, Vadodara, India
[4] JSS Acad Higher Educ & Res, JSS Med Coll, Dept Anat, Mysore, India
[5] Indira Gandhi Natl Tribal Univ, Dept Biotechnol, Amarkantak, India
[6] Indian Council Med Res, Reg Med Res Ctr, Bhubaneswar, India
[7] Andhra Univ, Dept Human Genet, Visakhapatnam, India
[8] Bodoland Univ, Dept Biotechnol, Kokrajhar, India
关键词
haemoglobinopathies; India; registry; screening; sickle cell disease; CHILDREN; SURVIVAL; ADULTS;
D O I
10.1002/hpm.3674
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
In India, sickle cell disease (SCD) predominantly occurs in indigenous (tribal) people, who are about 104 million. However, screening and diagnosis seldom happen. This situation necessitates developing a comprehensive SCD care model, including a registry. This paper describes the development and implementation of the Indian SCD registry (ISCDR) in six tribal-dominated districts of India. The ISCDR was created in two components-(i) an Android-based mobile/tablet application, (ii) a dashboard/admin panel for patients' data management and retrieval. Data capture involves two electronic case report forms (CRF), that is, the primary form (CRF-1) and the repeat visit form (CRF-2). CRF-1 is completed as soon as the patient is found positive and captures the patient's information, including medical history, diagnosis, symptoms, precipitating factors, hospitalisation history and treatment received. Issues related to quality, security and data-sharing were addressed. After the screening system was functional, ISCDR was initiated. In 12 months, data of 324 SCD patients and 1771 carriers were entered. The study demonstrates the feasibility of establishing an SCD registry in India. It collects systematic longitudinal data on SCD patients, which are essential for programme planning and management. Further, it is feasible to scale up and integrate with other health management databases.
引用
收藏
页码:1483 / 1494
页数:12
相关论文
共 50 条
  • [1] Effective Recruitment Strategies for a Sickle Cell Patient Registry Across Sites from the Sickle Cell Disease Implementation Consortium (SCDIC)
    Rita V. Masese
    Terri DeMartino
    Emily Bonnabeau
    Ebony N. Burns
    Liliana Preiss
    Taniya Varughese
    Judith M. Nocek
    Patricia Lasley
    Yumei Chen
    Caroline Davila
    Chinonyelum Nwosu
    Samantha Scott
    Latanya Bowman
    Lauren Gordon
    Cindy Clesca
    Marlene Peters-Lawrence
    Cathy Melvin
    Nirmish Shah
    Paula Tanabe
    Journal of Immigrant and Minority Health, 2021, 23 : 725 - 732
  • [2] Effective Recruitment Strategies for a Sickle Cell Patient Registry Across Sites from the Sickle Cell Disease Implementation Consortium (SCDIC)
    Masese, Rita V.
    DeMartino, Terri
    Bonnabeau, Emily
    Burns, Ebony N.
    Preiss, Liliana
    Varughese, Taniya
    Nocek, Judith M.
    Lasley, Patricia
    Chen, Yumei
    Davila, Caroline
    Nwosu, Chinonyelum
    Scott, Samantha
    Bowman, Latanya
    Gordon, Lauren
    Clesca, Cindy
    Peters-Lawrence, Marlene
    Melvin, Cathy
    Shah, Nirmish
    Tanabe, Paula
    JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 2021, 23 (04) : 725 - 732
  • [3] Mortality in adults with sickle cell disease: Results from the sickle cell disease implementation consortium (SCDIC) registry
    Njoku, Franklin
    Pugh, Norma
    Brambilla, Donald
    Kroner, Barbara
    Shah, Nirmish
    Treadwell, Marsha
    Gibson, Robert
    Hsu, Lewis L.
    Gordeuk, Victor R.
    Glassberg, Jeffrey
    Hankins, Jane S.
    Kutlar, Abdullah
    King, Allison A.
    Kanter, Julie
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (05) : 900 - 909
  • [4] Mortality in Adults with Sickle Cell Disease: Results from the Sickle Cell Disease Implementation Consortium (SCDIC) Registry
    Njoku, Franklin
    Pugh, Norma
    Treadwell, Marsha
    Glassberg, Jeffrey A.
    Kutlar, Abdullah
    Gibson, Robert
    Shah, Nirmish
    Gordeuk, Victor R.
    Hsu, Lewis L.
    Hankins, Jane
    King, Allison A.
    Kanter, Julie
    BLOOD, 2022, 140 : 2586 - 2588
  • [5] Management of the Dialysis Patient with Sickle Cell Disease
    Boyle, Suzanne M.
    Jacobs, Benjamin
    Sayani, Farzana A.
    Hoffman, Brenda
    SEMINARS IN DIALYSIS, 2016, 29 (01) : 62 - 70
  • [6] Challenges in the management of the transgender patient with sickle cell disease
    Ronda, Jocelyn
    Nord, Anne
    Arrington-Sanders, Renata
    Naik, Rakhi
    Takemoto, Clifford M.
    Baskin, Jacquelyn
    Lanzkron, Sophie
    Pecker, Lydia H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (11) : E360 - E362
  • [7] Management of a Patient with Sickle Cell Disease in an Emergency Room
    Kassasseya, C.
    Bressand, S.
    Khellaf, M.
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2022, 12 (04): : 234 - 240
  • [8] Management of a Sickle Cell Disease Patient with Severe Thrombocytosis
    Acosta, F.
    Klein, K.
    Tint, H.
    Castillo, B.
    Bai, Y.
    TRANSFUSION, 2016, 56 : 88A - 88A
  • [9] Sickle cell disease in Indian tribal population: Findings of a multi-centre Indian SCD registry
    Sharma, Yogita
    Bhat, Deepa
    Sridevi, Parikipandla
    Surti, Shaily B.
    Ranjit, Manoranjan
    Sarmah, Jatin
    Sudhakar, Godi
    Babu, Bontha, V
    BLOOD CELLS MOLECULES AND DISEASES, 2024, 109
  • [10] Infertility and treatment-seeking practices among females and males with sickle cell disease in the Sickle Cell Disease Implementation Consortium registry
    Stevenson, Eleanor
    Tanabe, Paula
    Knisely, Mitchell
    Masese, Rita
    Bulgin, Dominique
    Preiss, Liliana
    Hankins, Jane S. S.
    King, Allison A. A.
    Gordeuk, Victor
    Shah, Nirmish
    PEDIATRIC BLOOD & CANCER, 2023, 70 (07)